VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,732,000 | +2278.4% | 200,000 | +1900.0% | 2.11% | +606.4% |
| Q3 2022 | $241,000 | -92.9% | 10,000 | -90.0% | 0.30% | -71.1% |
| Q2 2021 | $3,398,000 | -64.9% | 100,000 | -69.7% | 1.04% | -38.6% |
| Q4 2019 | $9,674,000 | +22.9% | 330,400 | -22.3% | 1.68% | -30.0% |
| Q3 2018 | $7,871,000 | -63.5% | 425,000 | -56.6% | 2.41% | -60.0% |
| Q1 2018 | $21,540,000 | +826.9% | 980,000 | +880.0% | 6.02% | +570.7% |
| Q4 2017 | $2,324,000 | – | 100,000 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |